Albackr Hanan B, Alhabib Khalid F, Ullah Anhar, Alfaleh Hussam, Hersi Ahmad, Alshaer Fayez, Alnemer Khalid, Al Saif Shukri, Taraben Amir, Kashour Tarek
aKing Fahad Cardiac Center, College of Medicine, King Saud University bSecurity Forces Hospital cDepartment of Medicine, Prince Salman Heart Center, King Fahad Medical City, Riyadh dSaud Al-Babtain Cardiac Center, Dammam eKing Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
Coron Artery Dis. 2013 Nov;24(7):596-601. doi: 10.1097/MCA.0b013e328364d98f.
The aim of this study was to assess the prevalence, clinical features, and in-hospital outcomes of heart failure in patients with acute coronary syndrome (ACS).
The Saudi Project for Assessment of Coronary Events recruited patients admitted with ACS from 17 hospitals in Saudi Arabia from 2005 to 2007. The outcomes of ACS patients with congestive heart failure (CHF) compared with those without CHF were analyzed.
A total of 4523 patients with ACS were identified, of whom 905 (20%) had CHF. Compared with no CHF, patients with CHF were older (62±13.1 vs. 57±12.9 years; P=0.001), less likely to be men (70 vs. 79%; P=0.001), likely to present with non-ST-segment elevation myocardial infarction (48 vs. 36%; P=0.001), likely to have diabetes (71 vs. 54%; P=0.001), hypertension (64 vs. 54%; P=0.001) and previous history of coronary artery disease (53 vs. 43%; P=0.001), and likely to have significant left ventricular systolic dysfunction (left ventricular ejection fraction <35%) (56 vs. 30%; P=0.001). Patients with CHF were less likely to receive in-hospital β-blockers (74 vs. 86%; P=0.001) and a percutaneous coronary intervention (19 vs. 50%; P=0.001). Adjusted in-hospital mortality and cardiogenic shock were higher in the CHF group (odds ratio 4.43, 95% confidence interval 2.52-7.78; and odds ratio 3.51, 95% confidence interval 2.23-5.52), respectively.
ACS patients with CHF in the Saudi Project for Assessment of Coronary Events were older, more likely to have more cardiac risk factors, and less likely to be treated with optimum medical treatment on admission. These findings were associated with higher incidence of their in-hospital adverse outcomes. More aggressive treatment is warranted to improve prognosis.
本研究旨在评估急性冠状动脉综合征(ACS)患者心力衰竭的患病率、临床特征及院内结局。
沙特冠状动脉事件评估项目于2005年至2007年从沙特阿拉伯17家医院招募了因ACS入院的患者。分析了合并充血性心力衰竭(CHF)的ACS患者与未合并CHF的患者的结局。
共识别出4523例ACS患者,其中905例(20%)患有CHF。与未患CHF的患者相比,患CHF的患者年龄更大(62±13.1岁对57±12.9岁;P = 0.001),男性比例更低(70%对79%;P = 0.001),更可能表现为非ST段抬高型心肌梗死(48%对36%;P = 0.001),更可能患有糖尿病(71%对54%;P = 0.001)、高血压(64%对54%;P = 0.001)及有冠状动脉疾病史(53%对43%;P = 0.001),且更可能有显著的左心室收缩功能障碍(左心室射血分数<35%)(56%对30%;P = 0.001)。患CHF的患者住院期间接受β受体阻滞剂治疗的可能性较小(74%对86%;P = 0.001),接受经皮冠状动脉介入治疗的可能性也较小(19%对50%;P = 0.001)。CHF组调整后的院内死亡率和心源性休克发生率更高(比值比4.43,95%置信区间2.52 - 7.78;比值比3.51,95%置信区间2.23 - 5.52)。
沙特冠状动脉事件评估项目中合并CHF的ACS患者年龄更大,更可能有更多的心脏危险因素,入院时接受最佳药物治疗可能性更小。这些发现与他们更高的院内不良结局发生率相关。需要更积极的治疗以改善预后。